Quince Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | — | $-90.3M | $-89.9M |
| FY2022 | — | $-52.0M | $-51.7M |
| FY2023 | — | $-34.6M | $-31.4M |
| FY2024 | — | $-57.3M | $-56.8M |
| FY2025 | — | $-58.1M | $-84.0M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | — | $-90.3M | $-89.9M |
| FY2022 | — | $-52.0M | $-51.7M |
| FY2023 | — | $-34.6M | $-31.4M |
| FY2024 | — | $-57.3M | $-56.8M |
| FY2025 | — | $-58.1M | $-84.0M |